bufomix easyhaler 80 mikrog/ dose / 4.5 mikrog/ dose
orion corporation - espoo - budesonid / formoterolfumaratdihydrat - inhalasjonspulver - 80 mikrog/ dose / 4.5 mikrog/ dose
bufomix easyhaler 160 mikrog / 4.5 mikrog
orion corporation - espoo - budesonid / formoterolfumaratdihydrat - inhalasjonspulver - 160 mikrog / 4.5 mikrog
symbicort mite turbuhaler 80 mikrog/ dose / 4.5 mikrog/ dose
astrazeneca - budesonid / formoterolfumaratdihydrat - inhalasjonspulver - 80 mikrog/ dose / 4.5 mikrog/ dose
symbicort turbuhaler 160 mikrog/ dose / 4.5 mikrog/ dose
astrazeneca - budesonid / formoterolfumaratdihydrat - inhalasjonspulver - 160 mikrog/ dose / 4.5 mikrog/ dose
symbicort forte turbuhaler 320 mikrog/ dose / 9 mikrog/ dose
astrazeneca - budesonid / formoterolfumaratdihydrat - inhalasjonspulver - 320 mikrog/ dose / 9 mikrog/ dose
livicort 64 mikrog/ dose
mcneil sweden ab - budesonid - nesespray, suspensjon - 64 mikrog/ dose
livicort 32 mikrog/ dose
mcneil sweden ab - budesonid - nesespray, suspensjon - 32 mikrog/ dose
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
entocort 2 mg/100 ml
2care4 aps - budesonid - tablett og væske til rektalvæske, suspensjon - 2 mg/100 ml
entocort 3 mg
2care4 aps - budesonid - depotkapsel, hard - 3 mg